v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:      
Net loss $ 341,011 $ (1,898,265) $ (153,815)
Adjustments to reconcile net loss to net cash used in operating activities:      
Amortization of debt discount and deferred finance costs   302,014 81,095
Stock-based compensation   2,372,257
Gain on derecognition of non-financial asset (1,100,000) (1,100,000)
Change in fair value equity investment (300,000) (300,000)
Common shares issued to investors   130,766
Change in fair value of derivative (102,868) (12,788) (424,830)
Changes in operating assets and liabilities:      
Accounts receivable   49,266
Prepaids and other current assets   (214,599) (1,487)
Accounts payable and accrued liabilities   235,882 204,904
Accounts payable to related party   1,027 1,027
Net cash used in operating activities   (434,440) (293,106)
Cash flows from financing activities:      
Proceeds from sales of common stock under equity purchase agreement 6,630 6,630
Net proceeds from convertible debt   500,000
Proceeds from short term loans, others   57,922 295,000
Repaid to related party/others   (32,955)
Net cash provided by financing activities   531,597 295,000
Net increase in cash   97,157 1,894
Cash and restricted cash - beginning of period   108,857 106,128
Cash and restricted cash - end of period $ 206,014 206,014 108,022
Supplemental cash flow information:      
Interest paid   163,597 175,650
Non-cash investing and financing activities:      
Common stock issued in connection with debt   163,495
Common shares issued upon conversion of debt   847,470 70,198
Equity investment in exchange for non-financial asset   $ 1,100,000